HIV treatment failure in tertiary care: clinical epidemiology and preliminary mechanistic characterisation

Background: Despite antiretroviral therapy (ART) scale-up in sub-Saharan Africa, treatment failure remains a significant challenge. We characterised virological and immunological outcomes among people living with HIV (PLHIV) attending tertiary care facilities in Nigeria, with exploratory analysis of potential mechanistic factors. Methods: = 35) in pilot subsets. Results: < 0.01). Conclusion: HIV treatment outcomes at Nigerian tertiary facilities fall substantially short of global targets. The high prevalence of discordant immune-virological responses and preliminary evidence of drug resistance and immune activation suggest multiple interacting pathways to treatment failure. Larger mechanistic studies are warranted to inform targeted interventions.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-04-01
DOI
https://doi.org/10.3389/fpubh.2026.1777588
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HIV treatment failure in tertiary care: clinical epidemiology and preliminary mechanistic characterisation

Chukwuma Anyaike, Deborah Maigawu Buba, Philomena E. Airiohuodion, Peter Mac Asaga et al.
Frontiers in Public Health
HIV/AIDS drug development and treatment
article

HIV treatment failure in tertiary care: clinical epidemiology and preliminary mechanistic characterisation

Chukwuma Anyaike, Deborah Maigawu Buba, Philomena E. Airiohuodion, Peter Mac Asaga, Arthur Oragwa, Axel Kroeger, Sunday Omilabu
article en

Abstract

Background: Despite antiretroviral therapy (ART) scale-up in sub-Saharan Africa, treatment failure remains a significant challenge. We characterised virological and immunological outcomes among people living with HIV (PLHIV) attending tertiary care facilities in Nigeria, with exploratory analysis of potential mechanistic factors. Methods: = 35) in pilot subsets. Results: < 0.01). Conclusion: HIV treatment outcomes at Nigerian tertiary facilities fall substantially short of global targets. The high prevalence of discordant immune-virological responses and preliminary evidence of drug resistance and immune activation suggest multiple interacting pathways to treatment failure. Larger mechanistic studies are warranted to inform targeted interventions.

Frontiers in Public HealthVol. 14
University of Jos (NG), University of Lagos (NG), University Medical Center Freiburg (DE)
Good health and well-being
Openalex Percentile: Top 29%
HIV/AIDS drug development and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

HIV treatment failure in tertiary care: clinical epidemiology and preliminary mechanistic characterisation — Chukwuma Anyaike, Deborah Maigawu Buba, et al. · Frontiers in Public Health (2026) | TGRS Research Map | TGRS